Global HER2 Target Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global HER2 Target Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Activation of the epidermal growth factor receptor (EGFR) family of transmembrane receptor tyrosine kinases can regulate signaling pathways for cell proliferation and survival. HER2 is a non-ligand-binding member of this family and exerts its activity through heterodimerization with other EGFR family members. Activation of HER2 function can promote tumorigenesis, so scientists have begun research on HER2-targeted drugs in HER2 gene-related cancers.
The Global Info Research report includes an overview of the development of the HER2 Target Drugs industry chain, the market status of Breast Cancer (Monoclonal Antibodies, Small Molecule Chemicals), Colorectal Cancer (Monoclonal Antibodies, Small Molecule Chemicals), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of HER2 Target Drugs.
Regionally, the report analyzes the HER2 Target Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global HER2 Target Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the HER2 Target Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the HER2 Target Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, Small Molecule Chemicals).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the HER2 Target Drugs market.
Regional Analysis: The report involves examining the HER2 Target Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the HER2 Target Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to HER2 Target Drugs:
Company Analysis: Report covers individual HER2 Target Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards HER2 Target Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Breast Cancer, Colorectal Cancer).
Technology Analysis: Report covers specific technologies relevant to HER2 Target Drugs. It assesses the current state, advancements, and potential future developments in HER2 Target Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the HER2 Target Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
HER2 Target Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe HER2 Target Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HER2 Target Drugs, with price, sales, revenue and global market share of HER2 Target Drugs from 2018 to 2023.
Chapter 3, the HER2 Target Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HER2 Target Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and HER2 Target Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of HER2 Target Drugs.
Chapter 14 and 15, to describe HER2 Target Drugs sales channel, distributors, customers, research findings and conclusion.
Activation of the epidermal growth factor receptor (EGFR) family of transmembrane receptor tyrosine kinases can regulate signaling pathways for cell proliferation and survival. HER2 is a non-ligand-binding member of this family and exerts its activity through heterodimerization with other EGFR family members. Activation of HER2 function can promote tumorigenesis, so scientists have begun research on HER2-targeted drugs in HER2 gene-related cancers.
The Global Info Research report includes an overview of the development of the HER2 Target Drugs industry chain, the market status of Breast Cancer (Monoclonal Antibodies, Small Molecule Chemicals), Colorectal Cancer (Monoclonal Antibodies, Small Molecule Chemicals), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of HER2 Target Drugs.
Regionally, the report analyzes the HER2 Target Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global HER2 Target Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the HER2 Target Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the HER2 Target Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, Small Molecule Chemicals).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the HER2 Target Drugs market.
Regional Analysis: The report involves examining the HER2 Target Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the HER2 Target Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to HER2 Target Drugs:
Company Analysis: Report covers individual HER2 Target Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards HER2 Target Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Breast Cancer, Colorectal Cancer).
Technology Analysis: Report covers specific technologies relevant to HER2 Target Drugs. It assesses the current state, advancements, and potential future developments in HER2 Target Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the HER2 Target Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
HER2 Target Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Monoclonal Antibodies
- Small Molecule Chemicals
- Antibody Drug Conjugate
- Breast Cancer
- Colorectal Cancer
- Stomach Cancer
- Other
- Roche
- GSK
- Boehringer Digelheim
- Pfizer
- AstraZeneca
- Seagen
- MacroGenics
- Takeda
- Daiichi Sankyo
- Novartis AG
- RemeGen
- Sunshine Guojian
- Hengrui Medicine
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe HER2 Target Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HER2 Target Drugs, with price, sales, revenue and global market share of HER2 Target Drugs from 2018 to 2023.
Chapter 3, the HER2 Target Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HER2 Target Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and HER2 Target Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of HER2 Target Drugs.
Chapter 14 and 15, to describe HER2 Target Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of HER2 Target Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global HER2 Target Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Monoclonal Antibodies
1.3.3 Small Molecule Chemicals
1.3.4 Antibody Drug Conjugate
1.4 Market Analysis by Application
1.4.1 Overview: Global HER2 Target Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Breast Cancer
1.4.3 Colorectal Cancer
1.4.4 Stomach Cancer
1.4.5 Other
1.5 Global HER2 Target Drugs Market Size & Forecast
1.5.1 Global HER2 Target Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global HER2 Target Drugs Sales Quantity (2018-2029)
1.5.3 Global HER2 Target Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche HER2 Target Drugs Product and Services
2.1.4 Roche HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK HER2 Target Drugs Product and Services
2.2.4 GSK HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments/Updates
2.3 Boehringer Digelheim
2.3.1 Boehringer Digelheim Details
2.3.2 Boehringer Digelheim Major Business
2.3.3 Boehringer Digelheim HER2 Target Drugs Product and Services
2.3.4 Boehringer Digelheim HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boehringer Digelheim Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer HER2 Target Drugs Product and Services
2.4.4 Pfizer HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca HER2 Target Drugs Product and Services
2.5.4 AstraZeneca HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Seagen
2.6.1 Seagen Details
2.6.2 Seagen Major Business
2.6.3 Seagen HER2 Target Drugs Product and Services
2.6.4 Seagen HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Seagen Recent Developments/Updates
2.7 MacroGenics
2.7.1 MacroGenics Details
2.7.2 MacroGenics Major Business
2.7.3 MacroGenics HER2 Target Drugs Product and Services
2.7.4 MacroGenics HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 MacroGenics Recent Developments/Updates
2.8 Takeda
2.8.1 Takeda Details
2.8.2 Takeda Major Business
2.8.3 Takeda HER2 Target Drugs Product and Services
2.8.4 Takeda HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Takeda Recent Developments/Updates
2.9 Daiichi Sankyo
2.9.1 Daiichi Sankyo Details
2.9.2 Daiichi Sankyo Major Business
2.9.3 Daiichi Sankyo HER2 Target Drugs Product and Services
2.9.4 Daiichi Sankyo HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Daiichi Sankyo Recent Developments/Updates
2.10 Novartis AG
2.10.1 Novartis AG Details
2.10.2 Novartis AG Major Business
2.10.3 Novartis AG HER2 Target Drugs Product and Services
2.10.4 Novartis AG HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Novartis AG Recent Developments/Updates
2.11 RemeGen
2.11.1 RemeGen Details
2.11.2 RemeGen Major Business
2.11.3 RemeGen HER2 Target Drugs Product and Services
2.11.4 RemeGen HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 RemeGen Recent Developments/Updates
2.12 Sunshine Guojian
2.12.1 Sunshine Guojian Details
2.12.2 Sunshine Guojian Major Business
2.12.3 Sunshine Guojian HER2 Target Drugs Product and Services
2.12.4 Sunshine Guojian HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sunshine Guojian Recent Developments/Updates
2.13 Hengrui Medicine
2.13.1 Hengrui Medicine Details
2.13.2 Hengrui Medicine Major Business
2.13.3 Hengrui Medicine HER2 Target Drugs Product and Services
2.13.4 Hengrui Medicine HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hengrui Medicine Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HER2 TARGET DRUGS BY MANUFACTURER
3.1 Global HER2 Target Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global HER2 Target Drugs Revenue by Manufacturer (2018-2023)
3.3 Global HER2 Target Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of HER2 Target Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 HER2 Target Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 HER2 Target Drugs Manufacturer Market Share in 2022
3.5 HER2 Target Drugs Market: Overall Company Footprint Analysis
3.5.1 HER2 Target Drugs Market: Region Footprint
3.5.2 HER2 Target Drugs Market: Company Product Type Footprint
3.5.3 HER2 Target Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global HER2 Target Drugs Market Size by Region
4.1.1 Global HER2 Target Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global HER2 Target Drugs Consumption Value by Region (2018-2029)
4.1.3 Global HER2 Target Drugs Average Price by Region (2018-2029)
4.2 North America HER2 Target Drugs Consumption Value (2018-2029)
4.3 Europe HER2 Target Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific HER2 Target Drugs Consumption Value (2018-2029)
4.5 South America HER2 Target Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa HER2 Target Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global HER2 Target Drugs Sales Quantity by Type (2018-2029)
5.2 Global HER2 Target Drugs Consumption Value by Type (2018-2029)
5.3 Global HER2 Target Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global HER2 Target Drugs Sales Quantity by Application (2018-2029)
6.2 Global HER2 Target Drugs Consumption Value by Application (2018-2029)
6.3 Global HER2 Target Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America HER2 Target Drugs Sales Quantity by Type (2018-2029)
7.2 North America HER2 Target Drugs Sales Quantity by Application (2018-2029)
7.3 North America HER2 Target Drugs Market Size by Country
7.3.1 North America HER2 Target Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America HER2 Target Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe HER2 Target Drugs Sales Quantity by Type (2018-2029)
8.2 Europe HER2 Target Drugs Sales Quantity by Application (2018-2029)
8.3 Europe HER2 Target Drugs Market Size by Country
8.3.1 Europe HER2 Target Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe HER2 Target Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific HER2 Target Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific HER2 Target Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific HER2 Target Drugs Market Size by Region
9.3.1 Asia-Pacific HER2 Target Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific HER2 Target Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America HER2 Target Drugs Sales Quantity by Type (2018-2029)
10.2 South America HER2 Target Drugs Sales Quantity by Application (2018-2029)
10.3 South America HER2 Target Drugs Market Size by Country
10.3.1 South America HER2 Target Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America HER2 Target Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa HER2 Target Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa HER2 Target Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa HER2 Target Drugs Market Size by Country
11.3.1 Middle East & Africa HER2 Target Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa HER2 Target Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 HER2 Target Drugs Market Drivers
12.2 HER2 Target Drugs Market Restraints
12.3 HER2 Target Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of HER2 Target Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of HER2 Target Drugs
13.3 HER2 Target Drugs Production Process
13.4 HER2 Target Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 HER2 Target Drugs Typical Distributors
14.3 HER2 Target Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of HER2 Target Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global HER2 Target Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Monoclonal Antibodies
1.3.3 Small Molecule Chemicals
1.3.4 Antibody Drug Conjugate
1.4 Market Analysis by Application
1.4.1 Overview: Global HER2 Target Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Breast Cancer
1.4.3 Colorectal Cancer
1.4.4 Stomach Cancer
1.4.5 Other
1.5 Global HER2 Target Drugs Market Size & Forecast
1.5.1 Global HER2 Target Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global HER2 Target Drugs Sales Quantity (2018-2029)
1.5.3 Global HER2 Target Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche HER2 Target Drugs Product and Services
2.1.4 Roche HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK HER2 Target Drugs Product and Services
2.2.4 GSK HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments/Updates
2.3 Boehringer Digelheim
2.3.1 Boehringer Digelheim Details
2.3.2 Boehringer Digelheim Major Business
2.3.3 Boehringer Digelheim HER2 Target Drugs Product and Services
2.3.4 Boehringer Digelheim HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boehringer Digelheim Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer HER2 Target Drugs Product and Services
2.4.4 Pfizer HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca HER2 Target Drugs Product and Services
2.5.4 AstraZeneca HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Seagen
2.6.1 Seagen Details
2.6.2 Seagen Major Business
2.6.3 Seagen HER2 Target Drugs Product and Services
2.6.4 Seagen HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Seagen Recent Developments/Updates
2.7 MacroGenics
2.7.1 MacroGenics Details
2.7.2 MacroGenics Major Business
2.7.3 MacroGenics HER2 Target Drugs Product and Services
2.7.4 MacroGenics HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 MacroGenics Recent Developments/Updates
2.8 Takeda
2.8.1 Takeda Details
2.8.2 Takeda Major Business
2.8.3 Takeda HER2 Target Drugs Product and Services
2.8.4 Takeda HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Takeda Recent Developments/Updates
2.9 Daiichi Sankyo
2.9.1 Daiichi Sankyo Details
2.9.2 Daiichi Sankyo Major Business
2.9.3 Daiichi Sankyo HER2 Target Drugs Product and Services
2.9.4 Daiichi Sankyo HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Daiichi Sankyo Recent Developments/Updates
2.10 Novartis AG
2.10.1 Novartis AG Details
2.10.2 Novartis AG Major Business
2.10.3 Novartis AG HER2 Target Drugs Product and Services
2.10.4 Novartis AG HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Novartis AG Recent Developments/Updates
2.11 RemeGen
2.11.1 RemeGen Details
2.11.2 RemeGen Major Business
2.11.3 RemeGen HER2 Target Drugs Product and Services
2.11.4 RemeGen HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 RemeGen Recent Developments/Updates
2.12 Sunshine Guojian
2.12.1 Sunshine Guojian Details
2.12.2 Sunshine Guojian Major Business
2.12.3 Sunshine Guojian HER2 Target Drugs Product and Services
2.12.4 Sunshine Guojian HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sunshine Guojian Recent Developments/Updates
2.13 Hengrui Medicine
2.13.1 Hengrui Medicine Details
2.13.2 Hengrui Medicine Major Business
2.13.3 Hengrui Medicine HER2 Target Drugs Product and Services
2.13.4 Hengrui Medicine HER2 Target Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hengrui Medicine Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HER2 TARGET DRUGS BY MANUFACTURER
3.1 Global HER2 Target Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global HER2 Target Drugs Revenue by Manufacturer (2018-2023)
3.3 Global HER2 Target Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of HER2 Target Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 HER2 Target Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 HER2 Target Drugs Manufacturer Market Share in 2022
3.5 HER2 Target Drugs Market: Overall Company Footprint Analysis
3.5.1 HER2 Target Drugs Market: Region Footprint
3.5.2 HER2 Target Drugs Market: Company Product Type Footprint
3.5.3 HER2 Target Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global HER2 Target Drugs Market Size by Region
4.1.1 Global HER2 Target Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global HER2 Target Drugs Consumption Value by Region (2018-2029)
4.1.3 Global HER2 Target Drugs Average Price by Region (2018-2029)
4.2 North America HER2 Target Drugs Consumption Value (2018-2029)
4.3 Europe HER2 Target Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific HER2 Target Drugs Consumption Value (2018-2029)
4.5 South America HER2 Target Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa HER2 Target Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global HER2 Target Drugs Sales Quantity by Type (2018-2029)
5.2 Global HER2 Target Drugs Consumption Value by Type (2018-2029)
5.3 Global HER2 Target Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global HER2 Target Drugs Sales Quantity by Application (2018-2029)
6.2 Global HER2 Target Drugs Consumption Value by Application (2018-2029)
6.3 Global HER2 Target Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America HER2 Target Drugs Sales Quantity by Type (2018-2029)
7.2 North America HER2 Target Drugs Sales Quantity by Application (2018-2029)
7.3 North America HER2 Target Drugs Market Size by Country
7.3.1 North America HER2 Target Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America HER2 Target Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe HER2 Target Drugs Sales Quantity by Type (2018-2029)
8.2 Europe HER2 Target Drugs Sales Quantity by Application (2018-2029)
8.3 Europe HER2 Target Drugs Market Size by Country
8.3.1 Europe HER2 Target Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe HER2 Target Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific HER2 Target Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific HER2 Target Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific HER2 Target Drugs Market Size by Region
9.3.1 Asia-Pacific HER2 Target Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific HER2 Target Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America HER2 Target Drugs Sales Quantity by Type (2018-2029)
10.2 South America HER2 Target Drugs Sales Quantity by Application (2018-2029)
10.3 South America HER2 Target Drugs Market Size by Country
10.3.1 South America HER2 Target Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America HER2 Target Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa HER2 Target Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa HER2 Target Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa HER2 Target Drugs Market Size by Country
11.3.1 Middle East & Africa HER2 Target Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa HER2 Target Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 HER2 Target Drugs Market Drivers
12.2 HER2 Target Drugs Market Restraints
12.3 HER2 Target Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of HER2 Target Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of HER2 Target Drugs
13.3 HER2 Target Drugs Production Process
13.4 HER2 Target Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 HER2 Target Drugs Typical Distributors
14.3 HER2 Target Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global HER2 Target Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global HER2 Target Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche HER2 Target Drugs Product and Services
Table 6. Roche HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK HER2 Target Drugs Product and Services
Table 11. GSK HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Recent Developments/Updates
Table 13. Boehringer Digelheim Basic Information, Manufacturing Base and Competitors
Table 14. Boehringer Digelheim Major Business
Table 15. Boehringer Digelheim HER2 Target Drugs Product and Services
Table 16. Boehringer Digelheim HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Boehringer Digelheim Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer HER2 Target Drugs Product and Services
Table 21. Pfizer HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca HER2 Target Drugs Product and Services
Table 26. AstraZeneca HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AstraZeneca Recent Developments/Updates
Table 28. Seagen Basic Information, Manufacturing Base and Competitors
Table 29. Seagen Major Business
Table 30. Seagen HER2 Target Drugs Product and Services
Table 31. Seagen HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Seagen Recent Developments/Updates
Table 33. MacroGenics Basic Information, Manufacturing Base and Competitors
Table 34. MacroGenics Major Business
Table 35. MacroGenics HER2 Target Drugs Product and Services
Table 36. MacroGenics HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. MacroGenics Recent Developments/Updates
Table 38. Takeda Basic Information, Manufacturing Base and Competitors
Table 39. Takeda Major Business
Table 40. Takeda HER2 Target Drugs Product and Services
Table 41. Takeda HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Takeda Recent Developments/Updates
Table 43. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 44. Daiichi Sankyo Major Business
Table 45. Daiichi Sankyo HER2 Target Drugs Product and Services
Table 46. Daiichi Sankyo HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Daiichi Sankyo Recent Developments/Updates
Table 48. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 49. Novartis AG Major Business
Table 50. Novartis AG HER2 Target Drugs Product and Services
Table 51. Novartis AG HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Novartis AG Recent Developments/Updates
Table 53. RemeGen Basic Information, Manufacturing Base and Competitors
Table 54. RemeGen Major Business
Table 55. RemeGen HER2 Target Drugs Product and Services
Table 56. RemeGen HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. RemeGen Recent Developments/Updates
Table 58. Sunshine Guojian Basic Information, Manufacturing Base and Competitors
Table 59. Sunshine Guojian Major Business
Table 60. Sunshine Guojian HER2 Target Drugs Product and Services
Table 61. Sunshine Guojian HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Sunshine Guojian Recent Developments/Updates
Table 63. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 64. Hengrui Medicine Major Business
Table 65. Hengrui Medicine HER2 Target Drugs Product and Services
Table 66. Hengrui Medicine HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Hengrui Medicine Recent Developments/Updates
Table 68. Global HER2 Target Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global HER2 Target Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global HER2 Target Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in HER2 Target Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and HER2 Target Drugs Production Site of Key Manufacturer
Table 73. HER2 Target Drugs Market: Company Product Type Footprint
Table 74. HER2 Target Drugs Market: Company Product Application Footprint
Table 75. HER2 Target Drugs New Market Entrants and Barriers to Market Entry
Table 76. HER2 Target Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global HER2 Target Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global HER2 Target Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global HER2 Target Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global HER2 Target Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global HER2 Target Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global HER2 Target Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global HER2 Target Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global HER2 Target Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global HER2 Target Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global HER2 Target Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global HER2 Target Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global HER2 Target Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global HER2 Target Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global HER2 Target Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global HER2 Target Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global HER2 Target Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global HER2 Target Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global HER2 Target Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America HER2 Target Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America HER2 Target Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America HER2 Target Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America HER2 Target Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America HER2 Target Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America HER2 Target Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America HER2 Target Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America HER2 Target Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe HER2 Target Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe HER2 Target Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe HER2 Target Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe HER2 Target Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe HER2 Target Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe HER2 Target Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe HER2 Target Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe HER2 Target Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific HER2 Target Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific HER2 Target Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific HER2 Target Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific HER2 Target Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific HER2 Target Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific HER2 Target Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific HER2 Target Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific HER2 Target Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America HER2 Target Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America HER2 Target Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America HER2 Target Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America HER2 Target Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America HER2 Target Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America HER2 Target Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America HER2 Target Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America HER2 Target Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa HER2 Target Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa HER2 Target Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa HER2 Target Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa HER2 Target Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa HER2 Target Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa HER2 Target Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa HER2 Target Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa HER2 Target Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 135. HER2 Target Drugs Raw Material
Table 136. Key Manufacturers of HER2 Target Drugs Raw Materials
Table 137. HER2 Target Drugs Typical Distributors
Table 138. HER2 Target Drugs Typical Customers
Table 1. Global HER2 Target Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global HER2 Target Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche HER2 Target Drugs Product and Services
Table 6. Roche HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK HER2 Target Drugs Product and Services
Table 11. GSK HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Recent Developments/Updates
Table 13. Boehringer Digelheim Basic Information, Manufacturing Base and Competitors
Table 14. Boehringer Digelheim Major Business
Table 15. Boehringer Digelheim HER2 Target Drugs Product and Services
Table 16. Boehringer Digelheim HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Boehringer Digelheim Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer HER2 Target Drugs Product and Services
Table 21. Pfizer HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca HER2 Target Drugs Product and Services
Table 26. AstraZeneca HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AstraZeneca Recent Developments/Updates
Table 28. Seagen Basic Information, Manufacturing Base and Competitors
Table 29. Seagen Major Business
Table 30. Seagen HER2 Target Drugs Product and Services
Table 31. Seagen HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Seagen Recent Developments/Updates
Table 33. MacroGenics Basic Information, Manufacturing Base and Competitors
Table 34. MacroGenics Major Business
Table 35. MacroGenics HER2 Target Drugs Product and Services
Table 36. MacroGenics HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. MacroGenics Recent Developments/Updates
Table 38. Takeda Basic Information, Manufacturing Base and Competitors
Table 39. Takeda Major Business
Table 40. Takeda HER2 Target Drugs Product and Services
Table 41. Takeda HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Takeda Recent Developments/Updates
Table 43. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 44. Daiichi Sankyo Major Business
Table 45. Daiichi Sankyo HER2 Target Drugs Product and Services
Table 46. Daiichi Sankyo HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Daiichi Sankyo Recent Developments/Updates
Table 48. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 49. Novartis AG Major Business
Table 50. Novartis AG HER2 Target Drugs Product and Services
Table 51. Novartis AG HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Novartis AG Recent Developments/Updates
Table 53. RemeGen Basic Information, Manufacturing Base and Competitors
Table 54. RemeGen Major Business
Table 55. RemeGen HER2 Target Drugs Product and Services
Table 56. RemeGen HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. RemeGen Recent Developments/Updates
Table 58. Sunshine Guojian Basic Information, Manufacturing Base and Competitors
Table 59. Sunshine Guojian Major Business
Table 60. Sunshine Guojian HER2 Target Drugs Product and Services
Table 61. Sunshine Guojian HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Sunshine Guojian Recent Developments/Updates
Table 63. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 64. Hengrui Medicine Major Business
Table 65. Hengrui Medicine HER2 Target Drugs Product and Services
Table 66. Hengrui Medicine HER2 Target Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Hengrui Medicine Recent Developments/Updates
Table 68. Global HER2 Target Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global HER2 Target Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global HER2 Target Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in HER2 Target Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and HER2 Target Drugs Production Site of Key Manufacturer
Table 73. HER2 Target Drugs Market: Company Product Type Footprint
Table 74. HER2 Target Drugs Market: Company Product Application Footprint
Table 75. HER2 Target Drugs New Market Entrants and Barriers to Market Entry
Table 76. HER2 Target Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global HER2 Target Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global HER2 Target Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global HER2 Target Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global HER2 Target Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global HER2 Target Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global HER2 Target Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global HER2 Target Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global HER2 Target Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global HER2 Target Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global HER2 Target Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global HER2 Target Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global HER2 Target Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global HER2 Target Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global HER2 Target Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global HER2 Target Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global HER2 Target Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global HER2 Target Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global HER2 Target Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America HER2 Target Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America HER2 Target Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America HER2 Target Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America HER2 Target Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America HER2 Target Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America HER2 Target Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America HER2 Target Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America HER2 Target Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe HER2 Target Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe HER2 Target Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe HER2 Target Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe HER2 Target Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe HER2 Target Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe HER2 Target Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe HER2 Target Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe HER2 Target Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific HER2 Target Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific HER2 Target Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific HER2 Target Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific HER2 Target Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific HER2 Target Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific HER2 Target Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific HER2 Target Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific HER2 Target Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America HER2 Target Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America HER2 Target Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America HER2 Target Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America HER2 Target Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America HER2 Target Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America HER2 Target Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America HER2 Target Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America HER2 Target Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa HER2 Target Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa HER2 Target Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa HER2 Target Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa HER2 Target Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa HER2 Target Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa HER2 Target Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa HER2 Target Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa HER2 Target Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 135. HER2 Target Drugs Raw Material
Table 136. Key Manufacturers of HER2 Target Drugs Raw Materials
Table 137. HER2 Target Drugs Typical Distributors
Table 138. HER2 Target Drugs Typical Customers
LIST OF FIGURES
Figure 1. HER2 Target Drugs Picture
Figure 2. Global HER2 Target Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global HER2 Target Drugs Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Antibodies Examples
Figure 5. Small Molecule Chemicals Examples
Figure 6. Antibody Drug Conjugate Examples
Figure 7. Global HER2 Target Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global HER2 Target Drugs Consumption Value Market Share by Application in 2022
Figure 9. Breast Cancer Examples
Figure 10. Colorectal Cancer Examples
Figure 11. Stomach Cancer Examples
Figure 12. Other Examples
Figure 13. Global HER2 Target Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global HER2 Target Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global HER2 Target Drugs Sales Quantity (2018-2029) & (K Units)
Figure 16. Global HER2 Target Drugs Average Price (2018-2029) & (US$/Unit)
Figure 17. Global HER2 Target Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global HER2 Target Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of HER2 Target Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 HER2 Target Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 HER2 Target Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global HER2 Target Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global HER2 Target Drugs Consumption Value Market Share by Region (2018-2029)
Figure 24. North America HER2 Target Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe HER2 Target Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific HER2 Target Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. South America HER2 Target Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa HER2 Target Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. Global HER2 Target Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global HER2 Target Drugs Consumption Value Market Share by Type (2018-2029)
Figure 31. Global HER2 Target Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global HER2 Target Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global HER2 Target Drugs Consumption Value Market Share by Application (2018-2029)
Figure 34. Global HER2 Target Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America HER2 Target Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America HER2 Target Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America HER2 Target Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America HER2 Target Drugs Consumption Value Market Share by Country (2018-2029)
Figure 39. United States HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe HER2 Target Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe HER2 Target Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe HER2 Target Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe HER2 Target Drugs Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific HER2 Target Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific HER2 Target Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific HER2 Target Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific HER2 Target Drugs Consumption Value Market Share by Region (2018-2029)
Figure 55. China HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America HER2 Target Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America HER2 Target Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America HER2 Target Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America HER2 Target Drugs Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa HER2 Target Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa HER2 Target Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa HER2 Target Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa HER2 Target Drugs Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. HER2 Target Drugs Market Drivers
Figure 76. HER2 Target Drugs Market Restraints
Figure 77. HER2 Target Drugs Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of HER2 Target Drugs in 2022
Figure 80. Manufacturing Process Analysis of HER2 Target Drugs
Figure 81. HER2 Target Drugs Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. HER2 Target Drugs Picture
Figure 2. Global HER2 Target Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global HER2 Target Drugs Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Antibodies Examples
Figure 5. Small Molecule Chemicals Examples
Figure 6. Antibody Drug Conjugate Examples
Figure 7. Global HER2 Target Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global HER2 Target Drugs Consumption Value Market Share by Application in 2022
Figure 9. Breast Cancer Examples
Figure 10. Colorectal Cancer Examples
Figure 11. Stomach Cancer Examples
Figure 12. Other Examples
Figure 13. Global HER2 Target Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global HER2 Target Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global HER2 Target Drugs Sales Quantity (2018-2029) & (K Units)
Figure 16. Global HER2 Target Drugs Average Price (2018-2029) & (US$/Unit)
Figure 17. Global HER2 Target Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global HER2 Target Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of HER2 Target Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 HER2 Target Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 HER2 Target Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global HER2 Target Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global HER2 Target Drugs Consumption Value Market Share by Region (2018-2029)
Figure 24. North America HER2 Target Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe HER2 Target Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific HER2 Target Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. South America HER2 Target Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa HER2 Target Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. Global HER2 Target Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global HER2 Target Drugs Consumption Value Market Share by Type (2018-2029)
Figure 31. Global HER2 Target Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global HER2 Target Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global HER2 Target Drugs Consumption Value Market Share by Application (2018-2029)
Figure 34. Global HER2 Target Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America HER2 Target Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America HER2 Target Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America HER2 Target Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America HER2 Target Drugs Consumption Value Market Share by Country (2018-2029)
Figure 39. United States HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe HER2 Target Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe HER2 Target Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe HER2 Target Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe HER2 Target Drugs Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific HER2 Target Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific HER2 Target Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific HER2 Target Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific HER2 Target Drugs Consumption Value Market Share by Region (2018-2029)
Figure 55. China HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America HER2 Target Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America HER2 Target Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America HER2 Target Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America HER2 Target Drugs Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa HER2 Target Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa HER2 Target Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa HER2 Target Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa HER2 Target Drugs Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa HER2 Target Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. HER2 Target Drugs Market Drivers
Figure 76. HER2 Target Drugs Market Restraints
Figure 77. HER2 Target Drugs Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of HER2 Target Drugs in 2022
Figure 80. Manufacturing Process Analysis of HER2 Target Drugs
Figure 81. HER2 Target Drugs Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
